Ronald E. Reid

1.8k total citations
45 papers, 1.5k citations indexed

About

Ronald E. Reid is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Ronald E. Reid has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 6 papers in Oncology. Recurrent topics in Ronald E. Reid's work include Chemical Synthesis and Analysis (13 papers), Protein Structure and Dynamics (7 papers) and Aldose Reductase and Taurine (6 papers). Ronald E. Reid is often cited by papers focused on Chemical Synthesis and Analysis (13 papers), Protein Structure and Dynamics (7 papers) and Aldose Reductase and Taurine (6 papers). Ronald E. Reid collaborates with scholars based in Canada, United Kingdom and United States. Ronald E. Reid's co-authors include Robert S. Hodges, Thomas A. Grigliatti, K. Wayne Riggs, Onkar S. Bains, Liam J. Murphy, Jean Gariépy, Robert C. Brunham, Pele Chong, S. St‐Pierre and Ric M. Procyshyn and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Biochemistry.

In The Last Decade

Ronald E. Reid

44 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald E. Reid Canada 23 928 261 191 165 158 45 1.5k
Jean Marie Ruysschaert Belgium 27 1.6k 1.7× 381 1.5× 308 1.6× 100 0.6× 113 0.7× 90 2.5k
Daniel F. Wyss United States 31 1.6k 1.7× 171 0.7× 323 1.7× 132 0.8× 111 0.7× 58 3.4k
Donald Gantz United States 26 746 0.8× 113 0.4× 115 0.6× 102 0.6× 328 2.1× 59 1.6k
Rüdiger Pipkorn Germany 31 1.5k 1.6× 172 0.7× 229 1.2× 247 1.5× 39 0.2× 89 2.7k
Yutaka Saitoh Japan 27 1.5k 1.6× 138 0.5× 262 1.4× 264 1.6× 50 0.3× 91 2.9k
Scott D. Larsen United States 37 1.8k 2.0× 133 0.5× 365 1.9× 384 2.3× 43 0.3× 102 3.6k
Francesca Magherini Italy 26 1.3k 1.4× 90 0.3× 367 1.9× 240 1.5× 63 0.4× 80 2.2k
James T. Anderson United States 40 3.7k 4.0× 328 1.3× 255 1.3× 228 1.4× 56 0.4× 69 5.0k
L. D. Bergel'son Russia 27 1.7k 1.8× 90 0.3× 74 0.4× 216 1.3× 80 0.5× 135 2.5k
Olga Gursky United States 30 1.7k 1.8× 194 0.7× 215 1.1× 169 1.0× 644 4.1× 94 2.4k

Countries citing papers authored by Ronald E. Reid

Since Specialization
Citations

This map shows the geographic impact of Ronald E. Reid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald E. Reid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald E. Reid more than expected).

Fields of papers citing papers by Ronald E. Reid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald E. Reid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald E. Reid. The network helps show where Ronald E. Reid may publish in the future.

Co-authorship network of co-authors of Ronald E. Reid

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald E. Reid. A scholar is included among the top collaborators of Ronald E. Reid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald E. Reid. Ronald E. Reid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lubieniecka, Joanna M., Jinko Graham, Ronald E. Reid, et al.. (2013). A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor. Frontiers in Genetics. 4. 231–231. 53 indexed citations
2.
Bains, Onkar S., András Szeitz, Joanna M. Lubieniecka, et al.. (2013). A Correlation between Cytotoxicity and Reductase-Mediated Metabolism in Cell Lines Treated with Doxorubicin and Daunorubicin. Journal of Pharmacology and Experimental Therapeutics. 347(2). 375–387. 61 indexed citations
3.
4.
Bains, Onkar S., Thomas A. Grigliatti, Ronald E. Reid, & K. Wayne Riggs. (2010). Naturally Occurring Variants of Human Aldo-Keto Reductases with Reduced In Vitro Metabolism of Daunorubicin and Doxorubicin. Journal of Pharmacology and Experimental Therapeutics. 335(3). 533–545. 85 indexed citations
5.
Bains, Onkar S., et al.. (2009). Two Nonsynonymous Single Nucleotide Polymorphisms of Human Carbonyl Reductase 1 Demonstrate Reduced in Vitro Metabolism of Daunorubicin and Doxorubicin. Drug Metabolism and Disposition. 37(5). 1107–1114. 57 indexed citations
6.
Bains, Onkar S., et al.. (2009). Naturally Occurring Variants of Human CBR3 Alter Anthracycline In Vitro Metabolism. Journal of Pharmacology and Experimental Therapeutics. 332(3). 755–763. 41 indexed citations
7.
Takahashi, Ryan, Thomas A. Grigliatti, Ronald E. Reid, & K. Wayne Riggs. (2009). The Effect of Allelic Variation in Aldo-Keto Reductase 1C2 on the in Vitro Metabolism of Dihydrotestosterone. Journal of Pharmacology and Experimental Therapeutics. 329(3). 1032–1039. 15 indexed citations
8.
Bains, Onkar S., Ryan Takahashi, Tom Pfeifer, et al.. (2008). Two Allelic Variants of Aldo-Keto Reductase 1A1 Exhibit Reduced in Vitro Metabolism of Daunorubicin. Drug Metabolism and Disposition. 36(5). 904–910. 30 indexed citations
9.
Lakowski, Ted M., Gregory M. Lee, Mark Okon, Ronald E. Reid, & Lawrence P. McIntosh. (2007). Calcium‐induced folding of a fragment of calmodulin composed of EF‐hands 2 and 3. Protein Science. 16(6). 1119–1132. 32 indexed citations
10.
Reid, Ronald E., et al.. (2003). Human genetic variations in the 5HT2A receptor. Pharmacogenetics. 13(2). 107–118. 22 indexed citations
11.
Reid, Ronald E., et al.. (1999). Investigating Site-Specific Effects of the −X Glutamate in a Parvalbumin CD Site Model Peptide. Archives of Biochemistry and Biophysics. 372(1). 80–88. 6 indexed citations
12.
Reid, Ronald E., et al.. (1999). A Model for Circular Dichroism Monitored Dimerization and Calcium Binding in an EF-Hand Synthetic Peptide. Journal of Theoretical Biology. 199(2). 199–211. 10 indexed citations
13.
Reid, Ronald E., et al.. (1997). Conservative D133E Mutation of Calmodulin Site IV Drastically Alters Calcium Binding and Phosphodiesterase Regulation. Biochemistry. 36(12). 3608–3616. 15 indexed citations
14.
Procyshyn, Ric M. & Ronald E. Reid. (1994). An Examination of Glutamic Acid in the −X Chelating Position of the Helix-Loop-Helix Calcium Binding Motif. Archives of Biochemistry and Biophysics. 311(2). 425–429. 8 indexed citations
15.
Zhong, Guangming, István Tóth, Ronald E. Reid, & Robert C. Brunham. (1993). Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis .. The Journal of Immunology. 151(7). 3728–3736. 70 indexed citations
16.
17.
Luo, Jiangming, Ronald E. Reid, & Liam J. Murphy. (1990). Dexamethasone Increases Hepatic Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1) mRNA and Serum IGFBP-1 Concentrations in the Rat*. Endocrinology. 127(3). 1456–1462. 71 indexed citations
18.
Reid, Ronald E.. (1987). Total sequential solid phase synthesis of rabbit skeletal troponin C calcium binding site III. International journal of peptide & protein research. 30(5). 613–621. 10 indexed citations
19.
20.
Reid, Ronald E. & Robert S. Hodges. (1980). Co-operativity and calcium/magnesium binding to troponin C and muscle calcium binding parvalbumin: An hypothesis. Journal of Theoretical Biology. 84(3). 401–444. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean Marie Ruysschaert Breakdown of academic impact, for papers by Daniel F. Wyss Breakdown of academic impact, for papers by Donald Gantz Breakdown of academic impact, for papers by Rüdiger Pipkorn Breakdown of academic impact, for papers by Yutaka Saitoh Breakdown of academic impact, for papers by Scott D. Larsen Breakdown of academic impact, for papers by Francesca Magherini Breakdown of academic impact, for papers by James T. Anderson Breakdown of academic impact, for papers by L. D. Bergel'son Breakdown of academic impact, for papers by Olga Gursky
Rankless by CCL
2026